Results 301 to 310 of about 266,960 (356)

Multi-Collaborator Engagement to Identify Research Priorities for Early Intervention in Cerebral Palsy. [PDF]

open access: yesJ Clin Med
Shierk A   +8 more
europepmc   +1 more source

Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
In this study, we followed a group of children 2 to 6 years old with spastic cerebral palsy functioning in GMFCS levels I–III, over 3 years. Sixty‐five received BoNT‐A and 59 did not. Repeated BoNT‐A injections over 3 years were not associated with improvements in gross motor function or passive ankle dorsiflexion. Daily step counts, favouring the BoNT‐
Darcy Fehlings   +11 more
wiley   +1 more source

A Specific Haplotype of the <i>MMP2</i> Gene Promoter May Increase the Risk of Developing Cerebral Palsy. [PDF]

open access: yesDiagnostics (Basel)
Djuranovic Uklein A   +11 more
europepmc   +1 more source

A Traffic Light System for Detecting Spinal Deformities in Children with Cerebral Palsy. [PDF]

open access: yesChildren (Basel)
Westhoff B   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy